Microbot Medical Inc. (NASDAQ:MBOT – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.99 and traded as high as $1.03. Microbot Medical shares last traded at $1.01, with a volume of 189,160 shares traded.
Microbot Medical Price Performance
The firm has a market cap of $15.60 million, a PE ratio of -1.10 and a beta of 1.64. The company’s 50 day moving average price is $0.94 and its 200 day moving average price is $0.99.
Microbot Medical (NASDAQ:MBOT – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The biotechnology company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). Sell-side analysts expect that Microbot Medical Inc. will post -0.66 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Microbot Medical
About Microbot Medical
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
Featured Stories
- Five stocks we like better than Microbot Medical
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Texas Roadhouse Stock Steering for New Highs This Year
- The Significance of Brokerage Rankings in Stock Selection
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Investing in Construction Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.